Guidelines for Acromegaly Management: An Update
Шломо Мелмед(Cedars-Sinai Medical Center), Annamaria Colao(Federico II University Hospital), M. L. Vance(University of Virginia), Janet Schlechte(University of Iowa), Philippe Chanson(Bicêtre Hospital), Ashley Grossman(Queen Mary University of London), Edward R. Laws(Brigham and Women's Hospital), Ken K. Y. Ho(Garvan Institute of Medical Research), Mark E. Molitch(Christian Doppler Laboratory for Thermoelectricity), David L. Kleinberg(New York University), David R. Clemmons(University of North Carolina at Chapel Hill), Ariel L. Barkan(University of Michigan)
Cited by 763
Related Papers
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
|American Journal of Kidney Diseases|2014|896
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Effects of Testosterone Treatment in Older Men
|New England Journal of Medicine|2016|864
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
|Clinical Endocrinology|2006|830